DOD Biotech PCL (BKK:DOD) EPS (Basic): ฿0.02 (TTM As of Mar. 2026)


BKK:DOD DOD Biotech PCL BKK:DOD
76 GF Score
Price ฿1.50
GF Value ฿1.67
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is DOD Biotech PCL EPS (Basic)?

DOD Biotech PCL BKK:DOD 76 EPS (Basic) is ฿0.02 as of Mar. 2026. GuruFocus rates BKK:DOD with a GF Score™ of 76/100 and a GF Value™ of ฿1.67 (Modestly Undervalued). The stock has 4 warning signs investors should review.

DOD Biotech PCL's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was ฿-0.05. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was ฿0.02.

DOD Biotech PCL's EPS (Diluted) for the three months ended in Mar. 2026 was ฿-0.05. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ฿0.02.

DOD Biotech PCL's EPS without NRI for the three months ended in Mar. 2026 was ฿-0.03. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was 0.04.

During the past 12 months, DOD Biotech PCL's average EPS without NRIGrowth Rate was -5.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 12 years, DOD Biotech PCL's highest 3-Year average EPS without NRI Growth Rate was 94.60% per year. The lowest was -65.60% per year. And the median was -10.25% per year.

DOD Biotech PCL  (BKK:DOD) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

DOD Biotech PCL EPS (Basic) Related Terms

DOD Biotech PCL EPS (Basic) Historical Data

* Premium members only.

The historical data trend for DOD Biotech PCL's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DOD Biotech PCL EPS (Basic) Chart

DOD Biotech PCL Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.12 -0.97 0.02 -0.35 0.13

DOD Biotech PCL Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.02 0.02 0.03 -0.05
BKK:DOD
76GF Score
DOD Biotech PCL BKK:DOD
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DOD Biotech PCL EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

DOD Biotech PCL's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(59.587-0)/450.414
=0.13

DOD Biotech PCL's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-21.874-0)/450.414
=-0.05

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of ฿0.02 mean?
DOD Biotech PCL (BKK:DOD) has a EPS (Basic) of ฿0.02 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on DOD Biotech PCL and its competitors.
Is DOD Biotech PCL's EPS (Basic) too high?
DOD Biotech PCL's current EPS (Basic) is ฿0.02. Overall, DOD Biotech PCL has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does DOD Biotech PCL's EPS (Basic) compare to KHC and GIS?
DOD Biotech PCL's EPS (Basic) of ฿0.02 can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Consumer Packaged Goods company?
A good EPS (Basic) depends on the Consumer Packaged Goods industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on DOD Biotech PCL and its competitors. DOD Biotech PCL's current EPS (Basic) is ฿0.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DOD Biotech PCL stock overvalued right now?
Based on GuruFocus' analysis, DOD Biotech PCL (BKK:DOD) is currently considered Modestly Undervalued. The stock's GF Value™ is ฿1.67, compared to a current price of ฿1.50 — trading 10.2% below its estimated fair value. The current EPS (Basic) is ฿0.02. DOD Biotech PCL's overall GF Score™ is 76/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For DOD Biotech PCL (BKK:DOD), the current EPS (Basic) is ฿0.02 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is DOD Biotech PCL (BKK:DOD) Overvalued in 2026?

Based on GuruFocus' analysis, DOD Biotech PCL stock appears to be undervalued. The current stock price of ฿1.50 is trading 10.2% below its estimated GF Value™ of ฿1.67. GuruFocus considers DOD Biotech PCL to be Modestly Undervalued.

Key valuation signals for BKK:DOD:

  • EPS (Basic): ฿0.02
  • GF Value™: ฿1.67 vs. price of ฿1.50 (10.2% below fair value)
  • GF Score™: 76/100 with 4 warning signs

No single metric tells the full story. See the BKK:DOD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

DOD Biotech PCL Business Description

Address No. 111, Moo 2, Tumbol Taa jeen, Amphor Muengsamutsakhon, Samut Sakhon, THA, 74000
DOD Biotech PCL is principally engaged in the manufacture and distribution of food supplements and health drinks of all kinds. The group is principally engaged in the supplement business. Its operations are carried on only in Thailand. Its products include: Capsule; Gel; Jelly; Powder for making drinks; Concentrated water extract (Shot Drink); Softgel; Tablet; Probiotics; Gummies; and Direct-to-Mouth Packaging.
76GF Score

Get the complete analysis for BKK:DOD

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿1.50
Price
฿1.67
GF Value